Penalty Group 2 consists of:

(1) any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, if the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
• 5-(2-aminopropyl)benzofuran (5-APB);
• 6-(2-aminopropyl)benzofuran (6-APB);
• 5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-APDB);
• 6-(2-aminopropyl)-2,3-dihydrobenzofuran (6-APDB);
• 5-(2-aminopropyl)indole (5-IT,5-API);
• 6-(2-aminopropyl)indole (6-IT,6-API);
• 1-(benzofuran-5-yl)-N-methylpropan-2-amine (5-MAPB);
• 1-(benzofuran-6-yl)-N-methylpropan-2-amine (6-MAPB);
• Benzothiophenylcyclohexylpiperidine (BTCP);
• 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b’]difuran- 4-ethanamine (trade or other name: Bromo-DragonFLY);
• Desoxypipradrol (2-benzhydrylpiperidine);
• 2, 5-dimethoxyamphetamine (some trade or other names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
• Diphenylprolinol (diphenyl(pyrrolidin-2-yl) methanol, D2PM);
• Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product (some trade or other names for Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- (trans)- tetrahydrocannabinol);
• Ethylamine Analog of Phencyclidine (some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1- phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE);
• 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone (trade or other name: methoxetamine);
• Ibogaine (some trade or other names: 7-Ethyl-6, 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- pyrido [1′, 2′:1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
• 5-iodo-2-aminoindane (5-IAI);
• Mescaline;
• 5-methoxy-3, 4-methylenedioxy amphetamine;
• 4-methoxyamphetamine (some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA);
• 4-methoxymethamphetamine (PMMA);
• 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone (some trade and other names: 2-MeO-ketamine; methoxyketamine);
• 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, PPMP);
• 4-methyl-2, 5-dimethoxyamphetamine (some trade and other names: 4-methyl-2, 5-dimethoxy-alpha- methylphenethylamine; “DOM”; “STP”);
• 3,4-methylenedioxy methamphetamine (MDMA, MDM);
• 3,4-methylenedioxy amphetamine;
• 3,4-methylenedioxy N-ethylamphetamine (Also known as N-ethyl MDA);
• 5,6-methylenedioxy-2-aminoindane (MDAI);
• Nabilone (Another name for nabilone: (+)-trans- 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, 6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
• N-benzylpiperazine (some trade or other names: BZP; 1-benzylpiperazine);
• N-ethyl-3-piperidyl benzilate;
• N-hydroxy-3,4-methylenedioxyamphetamine (Also known as N-hydroxy MDA);
• 4-methylaminorex;
• N-methyl-3-piperidyl benzilate;
• Parahexyl (some trade or other names: 3-Hexyl-1- hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] pyran; Synhexyl);
• 1-Phenylcyclohexylamine;
• 1-Piperidinocyclohexanecarbonitrile (PCC);
• Pyrrolidine Analog of Phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
• Tetrahydrocannabinols, other than marihuana, and synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as:
• delta-1 cis or trans tetrahydrocannabinol, and their optical isomers;
• delta-6 cis or trans tetrahydrocannabinol, and their optical isomers;
• delta-3, 4 cis or trans tetrahydrocannabinol, and its optical isomers; or
• compounds of these structures, regardless of numerical designation of atomic positions, since nomenclature of these substances is not internationally standardized;
• Thiophene Analog of Phencyclidine (some trade or other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl Analog of Phencyclidine; TPCP, TCP);
• 1-pyrrolidine (some trade or other name: TCPy);
• 1-(3-trifluoromethylphenyl)piperazine (trade or other name: TFMPP); and
• 3,4,5-trimethoxy amphetamine;
(2) Phenylacetone (some trade or other names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl ketone);
(3) unless specifically excepted or unless listed in another Penalty Group, a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant or stimulant effect on the central nervous system:
• Aminorex (some trade or other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- phenyl-2-oxazolamine);
• Amphetamine, its salts, optical isomers, and salts of optical isomers;
• Cathinone (some trade or other names: 2-amino-1- phenyl-1-propanone, alpha-aminopropiophenone, 2- aminopropiophenone);
• Etaqualone and its salts;
• Etorphine Hydrochloride;
• Fenethylline and its salts;
• Lisdexamfetamine, including its salts, isomers, and salts of isomers;
• Mecloqualone and its salts;
• Methaqualone and its salts;
• Methcathinone (some trade or other names: 2- methylamino-propiophenone; alpha-(methylamino)propriophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N- methylaminopropriophenone; monomethylpropion; ephedrone, N- methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR 1431);
• N-Ethylamphetamine, its salts, optical isomers, and salts of optical isomers; and
• N,N-dimethylamphetamine (some trade or other names: N,N,alpha-trimethylbenzeneethanamine; N,N,alpha-trimethylphenethylamine), its salts, optical isomers, and salts of optical isomers;
(4) any compound structurally derived from 2-aminopropanal by substitution at the 1-position with any monocyclic or fused-polycyclic ring system, including:
(A) compounds further modified by:
(i) substitution in the ring system to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), whether or not further substituted in the ring system by other substituents;
(ii) substitution at the 3-position with an alkyl substituent; or
(iii) substitution at the 2-amino nitrogen atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or inclusion of the 2-amino nitrogen atom in a cyclic structure; and
(B) by example, compounds such as:
• 4-Methylmethcathinone (Also known as Mephedrone);
• 3,4-Dimethylmethcathinone (Also known as 3,4-DMMC);
• 3-Fluoromethcathinone (Also known as 3-FMC);
• 4-Fluoromethcathinone (Also known as Flephedrone);
• 3,4-Methylenedioxy-N-methylcathinone (Also known as Methylone);
• 3,4-Methylenedioxypyrovalerone (Also known as MDPV);
• alpha-Pyrrolidinopentiophenone (Also known as alpha-PVP);
• Naphthylpyrovalerone (Also known as Naphyrone);
• alpha-Methylamino-valerophenone (Also known as Pentedrone);
• beta-Keto-N-methylbenzodioxolylpropylamine (Also known as Butylone);
• beta-Keto-N-methylbenzodioxolylpentanamine (Also known as Pentylone);
• beta-Keto-Ethylbenzodioxolylbutanamine (Also known as Eutylone); and
• 3,4-methylenedioxy-N-ethylcathinone (Also known as Ethylone);
(5) any compound structurally derived from tryptamine (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:
(A) by modification in any of the following ways:
(i) by substitution at the amine nitrogen atom of the sidechain to any extent with alkyl or alkenyl groups or by inclusion of the amine nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;
(ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain (alpha-position) with an alkyl or alkenyl group;
(iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl, alkylenedioxy, or halide substituents; or
(iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent; and
(B) including:
(i) ethers and esters of the controlled substances listed in this subdivision; and
(ii) by example, compounds such as:
• alpha-ethyltryptamine;
• alpha-methyltryptamine;
• Bufotenine (some trade and other names: 3-(beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin; 5-hydroxy-N, N- dimethyltryptamine; mappine);
• Diethyltryptamine (some trade and other names: N, N-Diethyltryptamine, DET);
• Dimethyltryptamine (trade or other name: DMT);
• 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DiPT);
• O-Acetylpsilocin (Trade or other name: 4-Aco-DMT);
• Psilocin; and
• Psilocybin;
(6) 2,5-Dimethoxyphenethylamine and any compound structurally derived from 2,5-Dimethoxyphenethylamine by substitution at the 4-position of the phenyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), including, by example, compounds such as:
• 4-Bromo-2,5-dimethoxyphenethylamine (trade or other name: 2C-B);
• 4-Chloro-2,5-dimethoxyphenethylamine (trade or other name: 2C-C);
• 2,5-Dimethoxy-4-methylphenethylamine (trade or other name: 2C-D);
• 4-Ethyl-2,5-dimethoxyphenethylamine (trade or other name: 2C-E);
• 4-Iodo-2,5-dimethoxyphenethylamine (trade or other name: 2C-I);
• 2,5-Dimethoxy-4-nitrophenethylamine (trade or other name: 2C-N);
• 2,5-Dimethoxy-4-(n)-propylphenethylamine (trade or other name: 2C-P);
• 4-Ethylthio-2,5-dimethoxyphenethylamine (trade or other name: 2C-T-2);
• 4-Isopropylthio-2,5-dimethoxyphenethylamine (trade or other name: 2C-T-4); and
• 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (trade or other name: 2C-T-7); and
(7) 2,5-Dimethoxyamphetamine and any compound structurally derived from 2,5-Dimethoxyamphetamine by substitution at the 4-position of the phenyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), including, by example, compounds such as:
• 4-Ethylthio-2,5-dimethoxyamphetamine (trade or other name: Aleph-2);
• 4-Isopropylthio-2,5-dimethoxyamphetamine (trade or other name: Aleph-4);
• 4-Bromo-2,5-dimethoxyamphetamine (trade or other name: DOB);
• 4-Chloro-2,5-dimethoxyamphetamine (trade or other name: DOC);
• 2,5-Dimethoxy-4-ethylamphetamine (trade or other name: DOET);
• 4-Iodo-2,5-dimethoxyamphetamine (trade or other name: DOI);
• 2,5-Dimethoxy-4-methylamphetamine (trade or other name: DOM);
• 2,5-Dimethoxy-4-nitroamphetamine (trade or other name: DON);
• 4-Isopropyl-2,5-dimethoxyamphetamine (trade or other name: DOIP); and
• 2,5-Dimethoxy-4-(n)-propylamphetamine (trade or other name: DOPR).
(b) For the purposes of Subsection (a)(1) only, the term “isomer” includes an optical, position, or geometric isomer.
(c) To the extent Subsection (a)(4), (5), (6), or (7) conflicts with another provision or this subtitle or another law, the other provision or the other law prevails. If a substance listed in this section is also listed in another penalty group, the listing in the other penalty group controls.